Aging without Dementia is Achievable: Current Evidence from Epidemiological Research
Abstract
Both the incidence and the prevalence of dementia increase exponentially with increasing age. This raises the question of whether dementia is an inevitable consequence of aging or whether aging without dementia is achievable. In this review article, we sought to summarize the current evidence from epidemiological and neuropathological studies that investigated this topic. Epidemiological studies have shown that dementia could be avoided even at extreme old ages (e.g., centenarians or supercentenarians). Furthermore, clinico-neuropathological studies found that nearly half of centenarians with dementia did not have sufficient brain pathology to explain their cognitive symptoms, while intermediate-to-high Alzheimer pathology was present in around one-third of very old people without dementia or cognitive impairment. This suggests that certain compensatory mechanisms (e.g., cognitive reserve or resilience) may play a role in helping people in extreme old ages escape dementia syndrome. Finally, evidence has been accumulating in recent years indicating that the incidence of dementia has declined in Europe and North America, which supports the view that the risk of dementia in late life is modifiable. Evidence has emerged that intervention strategies that promote general health, maintain vascular health, and increase cognitive reserve are likely to help preserve cognitive function till late life, thus achieving the goal of aging without dementia.
INTRODUCTION
Dementia is a clinical syndrome related to brain disorders characterized by the development of cognitive deficits that are severe enough to interfere with daily social and occupational functioning. Clinically, Alzheimer’s disease (AD) is the most common type of dementia (∼50%–70%), followed by vasculardementia (∼20%–25%), although neuropathological and neuroimaging studies have revealed that the total burden of mixed brain vascular and neurodegenerative pathologies is the most common cause of dementia symptoms, especially among very old people [1]. There is currently neither a cure nor a disease-modifying therapy for AD or dementia. Advanced age or living longer is the strongest risk factor for dementia; after 65 years of age, both the prevalence and the incidence of dementia double approximately every 5–6 years until age 90, and ∼30% of people aged ≥85 years might be affected by dementia [1, 2]. In addition, ∼80% of dementia cases occur in people aged ≥75 years [1, 3]. Furthermore, several studies have repeatedly shown that both the prevalence and the incidence of dementia steadily increase with age even in the extreme old ages (e.g., age ≥95 years) [4, 5]. This is a critical issue for public health and health policy development given the fact that the oldest old people (e.g., octogenarians, nonagenarians, and centenarians) are the fastest growing segment of the population, and that dementia has already posed a huge burden to our aging society. In 2015, dementia affected ∼47 million people worldwide, with the annual global cost being US$818 billion [6].
In the past decades, the view that dementia is an inevitable consequence of aging has been challenged by findings from multidisciplinary research. In this narrative review article, we briefly summarize current evidence from epidemiological and neuropathological studies supporting the contrary: that aging without dementia is achievable.
NOT ALL VERY OLD PEOPLE DEVELOP DEMENTIA
2.1Occurrence of dementia in centenarians
The exponential increases in both the incidence and the prevalence of dementia with increasing age until very advanced ages make the public assume that dementia is inevitable for individuals who are able to survive to 100 years and older. Although the oldest old adults are the fastest growing segment of the population, both the absolute number and proportion of centenarians remain relatively small in the population; in 2016, there were 0.5 millioncentenarians in the world, accounting for ∼7.5% of people aged ≥65 years [7]. People living a century and beyond have neared the extreme limits of human life while escaping or delaying the major age-related diseases. Thus, these extraordinary individuals embody the best model to address the crucial question concerning whether cognitive decline still increases in extreme old age [8]. However, very few population-based studies have a sufficiently large sample size to provide reliable estimates of dementia prevalence among centenarians. Some reports, usually with very small samples (e.g., n < 20), indeed showed that all the examined centenarians appeared to be demented [9]. However, systematic reviews of studies with large samples of centenarians (e.g., n≥100) indicate that dementia prevalence varies between 45% and 70%, and that male centenarians are more likely to be cognitively intact than their female contemporaries [8–14] (Table 1). Notably, the large-scale Danish Centenarians Study (n = 207) showed that around one-third of centenarians were classified as having either no signs of dementia at all (25%) or probably no dementia (12%) [13]. The Sydney study of near-centenarians and centenarians (n = 200) showed that only 40% of participants (mean age, 97.4 years) were impaired on both global cognitive and physical functioning [15]. This suggests that even among centenarians a considerable proportion is able to escape dementia, or that the clinical expression of dementia syndrome has been markedly delayed until the very end of exceptionally long lives. In addition, a large-scale electronic health records-based study in the UK (n = ∼11,000 centenarians) found that dementia was recorded in only 11% of people who reached 100 years of age [16]. While dementia may be underdiagnosed in medical records, results of this study may also suggest that centenarians as a selective group have a lower risk of certain age-related diseases such as dementia.
Table 1
Prevalence of dementia among centenarians: a summary of major population-based studies
| Authors (country) | Study sample | Diagnostic criteria | Prevalence |
| Samuelsson et al. (Sweden) [10] | Swedish Centenarian Study: n = 100, 82% Women | DSM-III | 27% (men 16%, women 30%) |
| Ravaglia et al. (Northern Italy) [11] | Northern Italy Centenarian Study: n = 92, 59% women | DSM-IV | 61.9% (men 50.0%, women 69.6%) |
| Gondo et al. (Tokyo, Japan) [12] | Tokyo Centenarian Study: n = 304, 78.6% women | CDR ≥1 | 61.8% (men 41.5%, women 67.4%) |
| Andersen-Ranberg et al. (Denmark) [13] | Longitudinal Study of Danish Centenarians: n = 207, 78.3% women | ICD-10, CDR | 50.7% |
| Richmond et al. (Australia) [14] | A convenience sample of centenarians, n = 188, 80% women | MMSE score <21 | 20.1% (men 15.6%, women 21.2%) |
CDR, Clinical Dementia Rating; DSM, Diagnostic and Statistical Manual of Mental Disorders; ICD, International Classification of Diseases; MMSE, Mini-Mental State Examination.
Data on the incidence of dementia among centenarians are sparse. The meta-analysis of population-based studies suggested that the pace of increasing incidence of AD and dementia with age slowed at advanced ages [17]. This was supported later by two population-based studies of octogenarians and even older adults, which suggested that the incidence of dementia continued to increase beyond age 90, but the rate of increase slowed or plateaued thereafter [18, 19]. These results suggest that the risk of dementia in the oldest old adults might not be related to the aging process itself.
Thus, current evidence from both prevalence and incidence studies of dementia appears to suggest that dementia is not an inevitable consequence of extreme old ages [15]. It is worth noting that studies of dementia in centenarians face methodological challenges such as small sample sizes, lack of representativeness of the population, high attrition rate, and difficulties in the cognitive assessment and accurate diagnosis of dementia [8, 20, 21].
2.2Alzheimer pathologies in the brains of centenarians and older adults
Postmortem studies revealed that the brains of most centenarians exhibited extensive co-occurrence of multiple pathologies such as arteriolosclerosis, Alzheimer pathologies, hippocampal sclerosis, Lewy body pathology, and cerebral amyloid angiopathy, while Alzheimer pathology was not universal (∼60% with “moderate” neuritic amyloid plaque densities) [22, 23]. These findings are similar to those from octogenarians and nonagenarians [24]. Supercentenarians (age ≥110 years) are extremely rare in the world population (∼50 living supercentenarians in 2016, http://www.grg.org). Neuropathological data on four Japanese supercentenarians showed that the brain shapes and weights in the gross neuropathological findings were well preserved and that there was only mild frontal or temporal lobe atrophy in all cases [25]. Further, three cases showed an intermediate load of Alzheimer pathologies, and one was characterized as primary age-related tauopathy, but neither Lewy body pathology nor hippocampal sclerosis was observed. Finally, all four cases exhibited relatively mild cerebral atherosclerosis (e.g., brain infarcts) and arteriolosclerosis (e.g., small vessel diseases). Thus, neuropathological alterations associated with aging appeared to be relatively mild to moderate in the brains of centenarians and even supercentenarians. Population-based neuroimaging data (e.g., amyloid PET/CT images) also showed that exceptional aging without Alzheimer pathophysiology seemed possible in individuals with multiple protective factors over their lifespans [26]. This suggests that certain mechanisms may protect against the neuropathological evolution of brain aging.
Given that mixed brain pathologies are common at the oldest old or extreme old ages and that ∼30% of centenarians show no symptoms of cognitive impairment or dementia, additional mechanisms such as cognitive reserve may help these people escape dementia symptoms [27]. Clinico-neuropathological studies support the role of cognitive reserve in centenarians. For instance, data from the Nun Study and the 100-Plus Study showed that some centenarians appeared to have no or minimal cognitive symptoms or dementia despite extensive neuropathologies in the brain [28, 29]. Reserve capacity can be built over a lifespan through high education, mentally complex jobs, leisure activities, and social engagement [30]. This suggests that dementia risk is potentially modifiable even in extreme old ages, which supports the view that dementia is not an inevitable consequence of aging.
TIME TRENDS IN OCCURRENCE OF DEMENTIA
In the last decade, there has been increasing interest in investigating secular trends in the incidence and the prevalence of dementia. A scenario concerning the past 3–4 decades has emerged from systematic reviews suggesting that the age-specific prevalence and incidence of dementia may have declined in Europe and North America but increased in Asian countries [1, 31].
3.1Secular trends in prevalence of dementia
Despite differences in methodological aspects across studies, the primary evidence from systematic reviews of population-based studies generally shows a stable or decreasing prevalence of dementia in Europe and North America [32–48] (also [1] and [31] for detailed references) (Table 2). Repeated cross-sectional surveys in Spain suggested that the prevalence of dementia was stable in women but decreased in men from 1988 to 1994 [35]. In Sweden, population-based surveys showed that since the 1970s the prevalence of dementia had been relatively stable [36, 37] or decreasing [39, 43]. In the United Kingdom, a large-scale study of community residents suggested a cohort effect on the age-specific prevalence of dementia such that later-born cohorts had a lower likelihood of dementia than those born earlier in the twentieth century [38]. This was supported by a modelling study of the English Longitudinal Study of Aging, which demonstrated that in England and Wales, the age- and sex-standardized prevalence of dementia declined from 2002 to 2013 [42]. In France, the PAQUID Study suggested that the prevalence of dementia increased from 1988 to 2008 when dementia was diagnosed according to clinical criteria, but decreased when dementia was defined using an algorithm [41]. The Danish study also suggested that from 1998 to 2010 more people lived into advanced ages (e.g., nonagenarians) with better cognitive functioning [49]. In the United States, studies have shown either a relatively stable or declining age-adjusted prevalence of dementia and cognitive impairment in the past 3–4 decades [32, 34, 50]. In Canada, an increased age-standardized prevalence of dementia was reported, along with a decline in incidence, which suggests that the survival of patients with dementia may have improved over time [33].
Table 2
Key findings from major population-based studies on time trends in prevalence of dementia
| Authors (country) | Study population and study periods | Diagnostic criteria | Trends in prevalence |
| North America | |||
| Hall et al. (Indiana, US) [32] | Indianapolis-Ibadan Dementia Project, age ≥65, 1992 to 2001 | Dementia: ICD-10 | Stable (African-Americans) |
| Kosteniuk et al. (Saskatchewan, Canada) [33] | Age ≥45, 2005–2006 to 2012–2013, annual prevalence | Dementia: Medical records (ICD-9, 10) | Increased |
| Langa et al. (US) [34] | US Health and Retirement Study, age ≥65, 2000 to 2012 | Dementia: validated self-report | Decreased |
| Europe | |||
| Lobo et al. (Zaragoza, Spain) [35] | Zaragoza Study, age ≥65, 1988–1989 to 1994–1996 | Dementia: DSM-IV | Overall stable; decreased in men |
| Qiu et al. (Stockholm, Sweden) [36] | Kungsholmen Projects, age ≥75, 1987–1989 to 2001–2004 | Dementia: DSM-III-R | Stable |
| Wiberg et al. (Gothenburg, Sweden) [37] | Gothenburg Study, age 70, 1976–1977 to 2000–2001 | Dementia: DSM-III-R | Stable |
| Matthews et al. (England, UK) [38] | CFAS, age ≥65, 1989–1994 to 2008–2011 | Dementia: Geriatric Mental State Scale | Decreased |
| Wimo et al. (Nordanstig, Sweden) [39] | Nordanstig Projects, age ≥78, 1995–1998 to 2001–2003 | Dementia: DSM-III-R | Decreased (north rural areas) |
| Doblhammer et al. (Germany) [40] | Health insurance claims database, age ≥65, 2007–2009 | Dementia, ICD-10 | Decreased, mainly in women |
| Pérès et al. (Bordeaux, France) [41] | PAQUID, age ≥65, 1988–1989 to 2007–2008 | Dementia: Clinical: DSM-III-R | Clinical diagnosis: increased |
| Algorithm | Algorithm-based diagnosis: decreased | ||
| Ahmadi-Abhari et al. (England and Wales, UK) [42] | English Longitudinal Study of Ageing, age ≥50, 2002 to 2013 | Dementia: DSM-IV | Decreased |
| Skoog et al. (Gothenburg, Sweden) [43] | Gothenburg 85-year-old study, age 85, 1986–1987 to 2008–2010 | Dementia: DSM-III-R | Decreased |
| Asia | |||
| Li et al. (Beijing, China) [44] | Urban residents, age ≥60, 1986 to 1997, 2 waves | Dementia: ICD-10, DSM-IV | Increased |
| Yu et al. (Hong Kong, China) [45] | Systematic review, age ≥70, 1995–2006 | Dementia: ICD-9, 10 | Increased |
| Chan et al. (Mainland China) [46] | Systematic review, age ≥55, 1990 to 2010 | Dementia and AD: various criteria | Increased |
| Kim et al. (Korea) [47] | Systematic review, age ≥60, 1990 to 2013 | Dementia, AD: various criteria | Increased slightly, especially AD |
| Ohara et al. (Hisayama, Japan) [48] | Hisayama Study, age ≥65, from 1985, 1992, 1998 and 2005 to 2012 | Dementia: DSM-III-R | Increased |
AD, Alzheimer’s disease; ICD, International Classification of Diseases; DSM, Diagnostic and Statistical Manual of Mental Disorders; CFAS, Cognitive Function and Ageing Studies.
By contrast, in the Asia-Pacific regions, systematic reviews showed that the prevalence of AD and other dementias in mainland China had increased steadily from the 1990s to 2010 across all age groups of people aged 55+ years [46], although the secular trends might be partly due to certain methodological variations over time (e.g., diagnostic procedure, the defining criteria, and the study settings) [51]. In Hong Kong, China, systematic review revealed that the prevalence of clinical dementia among people aged 70+ years doubled from 1995 (4.5%) to 2006 (9.3%) [45]. While studies that explore the time trends of dementia prevalence in geographically defined populations in China are still lacking, there is evidence suggesting that the prevalence of global cognitive impairment increased from 1998 to 2008 among the oldest old people [52]. In Japan, the Hisayama Study suggested that the age-specific prevalence of dementia, and AD in particular, has markedly increased from the 1980s to the 2010s, driven largely by an increasing incidence and improved survival of people with AD [48]. The increasing prevalence of dementia in Japan was supported by a systematic review even when carefully taking the main methodological variations into consideration [53]. Finally, a systematic review suggested a slight increase in the prevalence of dementia in the past 20 years in Korea, characterized by an increase in AD prevalence but a decrease in the prevalence of vasculardementia [47].
3.2Secular trends in incidence of dementia
While the time trends in the prevalence of dementia over time are determined by trends in the incidence of dementia and the duration of the disease, the secular trends in the incidence of dementia could indicate whether the risk of late-life dementia is modifiable. Several community-based studies in Europe (e.g., the Netherlands, France, Germany, and the UK) have shown that the incidence of dementia has been declining in the past 2–4 decades [33, 42, 44, 48, 50, 54–64] (Table 3). For instance, the Rotterdam Study reported a 25% decrease, though statistically marginal, in the incidence of all-cause dementia between 1990 and 2000 in people aged 55+ years [60]. Using an algorithmic diagnostic approach, the UK Cognitive Function and Aging Study showed a 20% decline in dementia incidence from 1989–1994 to 2008–2011, but only in men [62]. Similarly, the modelling study using data from the English Longitudinal Study of Ageing suggested a declining age-specific incidence of dementia that corresponded to 20% reduced dementia incidence over 20 years [42]. The French study showed that dementia incidence decreased when using an algorithmic approach to define dementia but was stable when clinical criteria were used [63]. In North America, the Framingham Heart Study showed a 20% decrease in dementia incidence from the late 1970s to the early 2010s [56]. Similarly, several additional population-based studies from the US and Canada also showed a declining incidence of dementia and AD in older adults from the 1990s through the 2010s [33, 55–59]. Although some studies in the US and the Netherlands showed a relatively stable incidence of dementia[50, 54, 64], no study from Europe or North America has reported an increasing trend in dementia incidence in older adults [42]. On the contrary, the study in an urban area of Beijing, China, and the well-defined Hisayama Study in Japan showed evidence of the incidence of dementia increasing since the 1980s[44, 48].
Table 3
Key findings from major population-based studies on time trends in incidence of dementia
| Authors (country) | Study population and study periods | Diagnostic criteria | Trends in incidence |
| North America | |||
| Rocca et al. (Minnesota, US) [50] | Minnesota, age ≥70, 1975–1994 | Dementia: ICD codes (similar to DSM-II-R) | Stable |
| Hebert et al. (Chicago, US) [54] | Chicago Health and Aging Project, age ≥65, 1993–2008 | AD: NINCDS-ADRDA criteria | Stable |
| Gao et al. (Indiana, US) [55] | Indianapolis-Ibadan Dementia Project, age ≥70, 1992 to 2001 | Dementia: DSM-III-R; AD: NINCDS-ADRDA | African-Americans: decreased |
| Satizabal et al. (Boston, US) [56] | FHS, age ≥60, 1977–1983 to 2003–2008, 4 time periods | Dementia: DSM-IV; AD: NINCDS-ADRDA | Decreased |
| Cerasuolo et al. (Ontario, Canada) [57] | Age ≥65, 2002 to 2013, annual incidence | Dementia: Medical records (ICD-9, 10) | Stable in age 65–79; decreased in age ≥80 |
| Derby et al. (New York, US) [58] | Einstein Aging Study, age ≥70, 1993–2015, annual incidence | Dementia: DSM-IV | Decreased |
| Kosteniuk et al. (Saskatchewan, Canada) [33] | Age ≥45, 2005–2006 to 2012–2013, annual incidence | Dementia: Medical records (ICD-9, 10) | Decreased |
| Noble et al. (New York, US) [59] | WHICAP (multiethnics), age ≥65, 1992–1994 to 1999–2001 | Dementia: DSM-IV | Decreased |
| Europe | |||
| Schrijvers et al. (The Netherlands) [60] | Rotterdam Study, age ≥60, 1990 to 2000 | Dementia: DSM-III-R | Decreased (p = 0.06) |
| Doblhammer et al. (Germany) [61] | Health insurance database, age ≥65, 2006–2007 to 2009–2010 | Dementia, ICD-10 | 10% decrease |
| Matthews et al. (England, UK) [62] | CFAS, age ≥65, 1991–1995 to 2008–2013 | Dementia: Similar to DSM-III-R | Decreased |
| Grasset et al. (Bordeaux, France) [63] | PAQUID and 3-City Studies, age ≥65, 1988–1989 to 1999–2000 | Dementia: Clinical: DSM-III-R; Algorithmic | Clinical diagnosis: stable Algorithm-based diagnosis: decline |
| van Bussel et al. (The Netherlands) [64] | Age ≥60, 1992 to 2014, annual incidence | Dementia: Primary care records | Stable |
| Ahmadi-Abhari et al. (England and Wales, UK) [42] | English Longitudinal Study of Ageing, age ≥50, 2002 to 2013 | Dementia: DSM-IV | Decreased |
| Asia | |||
| Li et al. (Beijing, China) [44] | Urban residents, age ≥60, 1986–1989 to 1997–1999 | Dementia: ICD-10, DSM-IV | Increased |
| Ohara et al. (Hisayama, Japan) [48] | Hisayama Study, age ≥65, 1988–1998 to 2002–2012 | Dementia: DSM-III-R; AD: NINCDS-ADRDA | Increased |
AD, Alzheimer’s disease; ICD, International Classification of Diseases; NINCDS-ADRDA, National Institute of Neurological Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association; DSM, Diagnostic and Statistical Manual of Mental Disorders; WHICAP, Washington Heights-Inwood Columbia Aging Project; FHS, Framingham Heart Study; CFAS, Cognitive Function and Ageing Studies.
3.3Possible explanation of different time trends in dementia occurrence
Given that the late-life occurrence of dementia is affected by numerous factors over a lifespan, it is not surprising that secular trends of dementia vary within and among countries. Evidence suggests that the decreasing incidence of dementia in Europe and North America might be partly attributable to higher education and better control of cardiovascular risk factors in successive cohorts [56, 59]. First, the increase in early-life educational attainment might contribute to cognitive reserve and better cognition later in life via a positive effect on brain development and mental stimulation over the life course (e.g., cognitively demanding jobs and leisure activities). Further, adopting a brain-healthy lifestyle (e.g., no smoking and regular exercise), better control of major vascular risk factors (e.g., hypertension, diabetes, and dyslipidemia), and better access to health care interventions may help maintain vascular health and reduce the overall burden of cerebrovascular and neurodegenerative pathologies, thus delaying the onset of dementia [42, 60]. Finally, societal evolution in Western societies in the past century such as improvements in living conditions and social welfare may have led to enhanced general health, thus contributing to the delayed onset of dementia [31]. Taken together, the declining incidence of dementia in recent decades may partly reflect a successful compression of cognitive morbidity in aging, as suggested in several studies [65–67].
More research is needed to understand time trends in the incidence of dementia in China. However, the upward trend in the prevalence of dementia from the 1990s to 2010 is consistent with the increasing epidemic of stroke, ischemic heart disease, and related lifestyle and metabolic risk factors (e.g., physical inactivity, obesity, and diabetes) over similar periods, together with a rapidly aging population [68]. In Japan, the increasing incidence of dementia may be associated with a decrease in the competing risk of premature death, along with the increasing epidemic of an unhealthy diet, physical inactivity, and diabetes [48]. Clarifying major modifiable factors that contribute to changes in dementia incidence in different regions will help develop effective intervention strategies and health policies.
INTERVENTIONS TO DELAY THE ONSET OF DEMENTIA
Current evidence supports the view that the risk of dementia appears to be modifiable through multimodal interventions, especially at critical time windows over a life course [69]. Intervention measures include promoting healthy lifestyles (e.g., no smoking, physical activity, and a balanced diet), reducing the cardiovascular risk burden (e.g., optimalcontrol of hypertension, diabetes, and high cholesterol), and increasing cognitive reserve (e.g., education, social engagement, and mental activities).
4.1Health promotion
Healthy aging in general is critical for healthy brain aging. Dementia and cardiovascular disease share commonrisk factors such as long-term hypertension, diabetes, an unbalanced diet, and obesity. Thus, health promotion initiatives for healthy brain aging and dementia risk reduction should be incorporated with those for cardiovascular health. The modifiable lifestyle and medical risk factors of dementia can be targeted for health promotion or primordial prevention [70]. In addition, a brain-healthy lifestyle can build brain and cognitive reserves, which helps to maintain cognitive functioning until the very end of life. Indeed, health promotion programs targeting the risk reduction of dementia have been developed in several countries (e.g., Australia, the US, Canada, France, and the UK) and by professional organizations (e.g., WHO, Alzheimer’s Disease International, and Age UK).
4.2Reduction of cardiovascular risk burden
Increasing evidence suggests that vascular mechanisms play a pivotal role in cognitive decline and dementia and that a clinical expression of the dementia syndrome involves complex interactions of convergent cerebrovascular and neurodegenerative processes in old people [71, 72]. Indeed, traditional cardiovascular risk factors such as midlife hypertension, diabetes, and high cholesterol, especially when occurring concurrently, confer a substantial risk for dementia and AD. This suggests that interventions targeting multiple major vascular risk factors may represent a promising approach to reducing dementia risk and delaying its onset. However, there remains a gap between the major findings of observational studies and randomized controlled trials, such that observational studies often show a reduced risk of dementia associated with the use of cardiovascular medications (e.g., antihypertensive drugs and statins), whereas randomized controlled clinical trials that targeted individual vascular risk factors such as hypertension, high cholesterol, or hyperglycemia have generally yielded negative results[69, 73]. Recently, multidomain intervention studies of unhealthy lifestyles, vascular risk factors, diet, and cognitive training have also shown mixed results [74–76]. Hopefully, the ongoing effort may provide additional evidence, which can help to form evidence-based recommendations for multimodal intervention against cognitive decline and dementia (e.g., World Wide FINGERS, http://wwfingers.com/)..
4.3Increasing brain and cognitive reserve
Cognitive reserve has been proposed as explaining (1) the link of higher education and more frequent participation in social and intellectual activities with resistance to cognitive decline, and (2) the discrepancy between the extent of Alzheimer pathology and the severity of cognitive symptoms [27]. Early-life greater educational achievement is the major driving factor for cognitive reserve. In addition, numerous prospective studies have reported that people who frequently engage in mentally stimulating activities (e.g., learning, reading, or playing games) from young adulthood through midlife and old age are less likely to develop dementia [77]. Finally, occupational complexity, social networks, and social engagement (e.g., frequent contacts with friends and relatives, attending clubs and church, and going to movies) also contribute to cognitive reserve and reduce the risk of cognitive impairment and dementia. Thus, enhancing cognitive capacity through increased educational attainment in early life and lifelong cognitive and social activities represents an alternative strategy to mitigate cognitive decline and postpone the onset of clinical dementia [30].
CONCLUSION
Epidemiological data show that dementia could be avoided even at extreme old ages (e.g., among centenarians or supercentenarians). This implies that people are able to reach very advanced ages without experiencing severe mental deterioration. Further, clinico-neuropathological studies of centenarians and even older people found that nearly half of those with dementia did not have sufficient brain neuropathology to explain their cognitive symptoms, while intermediate-to-high Alzheimer pathologies were present in around one-third of very old people without dementia or cognitive impairment. This suggests that certain compensatory mechanisms (e.g., cognitive reserve or cognitive resilience) may play a part in helping people escape the dementia syndrome in extreme old age. Finally, recent evidence of a declining incidence of dementia in Europe and North America suggests that the risk of late-lifedementia is modifiable. This supports the potential that intervention strategies that aim to promote general health, maintain vascular health, and increase cognitive reserve may indeed help achieve a lifewithout dementia.
ACKNOWLEDGMENTS
The authors declare no conflict of interest. This work was supported in part by grants from the Swedish Research Council for Health, Working Life and Welfare (2014-01382), the Swedish Research Council (2015-02531), and the Shandong Taishan Scholar Program.
Authors’ disclosures available online (https://www.j-alz.com/manuscript-disclosures/17-1037r1).
REFERENCES
[1] | Winblad B , Amouyel P , Andrieu S , Ballard C , Brayne C , Brodaty H , Cedazo-Minguez A , Dubois B , Edvardsson D , Feldman H , Fratiglioni L , Frisoni GB , Gauthier S , Georges J , Graff C , Iqbal K , Jessen F , Johansson G , Jönsson L , Kivipelto M , Knapp M , Mangialasche F , Melis R , Nordberg A , Rikkert MO , Qiu C , Sakmar TP , Scheltens P , Schneider LS , Sperling R , Tjernberg LO , Waldemar G , Wimo A , Zetterberg H ((2016) ) Defeating Alzheimer’s disease and other dementias: A priority for European science and society. Lancet Neurol 15: , 455–532. |
[2] | Prince M , Bryce R , Albanese E , Wimo A , Ribeiro W , Ferri CP ((2013) ) The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 9: , 63.e2–75.e2. |
[3] | Fratiglioni L , Qiu C ((2011) ) Prevention of cognitive decline in ageing: Dementia as the target, delayed onset as the goal. Lancet Neurol 10: , 778–779. |
[4] | Corrada MM , Brookmeyer R , Paganini-Hill A , Berlau D , Kawas CH ((2010) ) Dementia incidence continues to increase with age in the oldest old: The 90+ study. Ann Neurol 67: , 114–121. |
[5] | Lucca U , Tettamanti M , Logroscino G , Tiraboschi P , Landi C , Sacco L , Garrí M , Ammesso S , Bertinotti C , Biotti A , Gargantini E , Piedicorcia A , Nobili A , Pasina L , Franchi C , Djade CD , Riva E , Recchia A ((2015) ) Prevalence of dementia in the oldest old: The Monzino 80-plus population based study. Alzheimers Dement 11: , 258.e3–70.e3. |
[6] | Wimo A , Guerchet M , Ali GC , Wu YT , Prina AM , Winblad B , Jönsson L , Liu Z , Prince M ((2017) ) The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement 13: , 1–7. |
[7] | Robine JM , Cubaynes S ((2017) ) Worldwide demography of centenarians. Mech Ageing Dev 165: , 59–67. |
[8] | Arosio B , Ostan R , Mari D , Damanti S , Ronchetti F , Arcudi S , Scurti M , Franceschi C , Monti D ((2017) ) Cognitive status in the oldest old and centenarians: A condition crucial for quality of life methodologically difficult to assess. Mech Ageing Dev 165: , 185–194. |
[9] | Yang Z , Slavin MJ , Sachdev PS ((2013) ) Dementia in the oldest old. Nat Rev Neurol 9: , 382–393. |
[10] | Samuelsson SM , Alfredson BB , Hagberg B , Samuelsson G , Nordbeck B , Brun A , Gustafson L , Risberg J ((1997) ) The Swedish Centenarian Study: A multidisciplinary study of five consecutive cohorts at the age of 100. Int J Aging Hum Dev 45: , 223–253. |
[11] | Ravaglia G , Forti P , De Ronchi D , Maioli F , Nesi B , Cucinotta D , Bernardi M , Cavalli G ((1999) ) Prevalence and severity of dementia among northern Italian centenarians. Neurology 53: , 416–418. |
[12] | Gondo Y , Hirose N , Arai Y , Inagaki H , Masui Y , Yamamura K , Shimizu K , Takayama M , Ebihara Y , Nakazawa S , Kitagawa K ((2006) ) Functional status of centenarians in Tokyo, Japan: Developing better phenotypes of exceptional longevity. J Gerontol A Biol Sci Med Sci 61: , 305–310. |
[13] | Andersen-Ranberg K , Vasegaard L , Jeune B ((2001) ) Dementia is not inevitable: A population-based study of Danish centenarians. J Gerontol B Psychol Sci Soc Sci 56: , P152–159. |
[14] | Richmond RL , Law J , Kay-Lambkin F ((2011) ) Physical, mental, and cognitive function in a convenience sample of centenarians in Australia. J Am Geriatr Soc 59: , 1080–1086. |
[15] | Sachdev PS , Levitan C , Crawford J , Sidhu M , Slavin M , Richmond R , Kochan N , Brodaty H , Wen W , Kang K , Mather KA ((2011) ) The Sydney Centenarian Study: Methodology and profile of centenarians and near-centenarians. Int Psychogeriatr 25: , 993–1005. |
[16] | Hazra NC , Dregan A , Jackson S , Gulliford MC ((2015) ) Differences in health at age 100 according to sex: Population-based cohort study of centenarians using electronic health records. J Am Geriatr Soc 63: , 1331–1337. |
[17] | Gao S , Hendrie HC , Hall KS , Hui S ((1998) ) The relationships between age, sex, and the incidence of dementia and Alzheimer disease: A meta-analysis. Arch Gen Psychiatry 55: , 809–815. |
[18] | Hall CB , Verghese J , Sliwinski M , Chen Z , Katz M , Derby C , Lipton RB ((2005) ) Dementia incidence may increase more slowly after age 90: Results from the Bronx Aging Study. Neurology 65: , 882–886. |
[19] | Miech RA , Breitner JC , Zandi PP , Khachaturian AS , Anthony JC , Mayer L ((2002) ) Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology 58: , 209–218. |
[20] | Brodaty H , Woolf C , Andersen S , Barzilai N , Brayne C , Cheung KS , Corrada MM , Crawford JD , Daly C , Gondo Y , Hagberg B , Hirose N , Holstege H , Kawas C , Kaye J , Kochan NA , Lau BH , Lucca U , Marcon G , Martin P , Poon LW , Richmond R , Robine JM , Skoog I , Slavin MJ , Szewieczek J , Tettamanti M , Viña J , Perls T , Sachdev PS ((2016) ) ICC-dementia (International Centenarian Consortium - dementia): An international consortium to determine the prevalence and incidence of dementia in centenarians across diverse ethnoracial and sociocultural groups. BMC Neurol 16: , 52. |
[21] | Slavin MJ , Brodaty H , Sachdev PS ((2013) ) Challenges of diagnosing dementia in the oldest old population. J Gerontol A Biol Sci Med Sci 68: , 1103–1111. |
[22] | Mizutani T , Shimada H ((1992) ) Neuropathological background of twenty-seven centenarian brains. J Neurol Sci 108: , 168–177. |
[23] | Neltner JH , Abner EL , Jicha GA , Schmitt FA , Patel E , Poon LW , Marla G , Green RC , Davey A , Johnson MA , Jazwinski SM , Kim S , Davis D , Woodard JL , Kryscio RJ , Van Eldik LJ , Nelson PT ((2016) ) Brain pathologies in extreme old age. Neurobiol Aging 37: , 1–11. |
[24] | Brenowitz WD , Keene CD , Hawes SE , Hubbard RA , Longstreth WT Jr , Woltjer RL , Crane PK , Larson EB , Kukull WA ((2017) ) Alzheimer’s disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples. Neurobiol Aging 53: , 83–92. |
[25] | Takao M , Hirose N , Arai Y , Mihara B , Mimura M ((2016) ) Neuropathology of supercentenarians - four autopsy case studies. Acta Neuropathol Commun 4: , 97. |
[26] | Vemuri P , Knopman DS , Lesnick TG , Przybelski SA , Mielke MM , Graff-Radford J , Murray ME , Roberts RO , Vassilaki M , Lowe VJ , Machulda MM , Jones DT , Petersen RC , Jack CR Jr ((2017) ) Evaluation of amyloid protective factors and Alzheimer disease neurodegeneration protective factors in elderly individuals. JAMA Neurol 74: , 718–726. |
[27] | Stern Y ((2012) ) Cognitive reserve in ageing and Alzheimer’s disease. Lancet Neurol 11: , 1006–1012. |
[28] | Snowdon DA ((2003) ) Healthy aging and dementia: Findings from the Nun Study. Ann Intern Med 139: , 450–454. |
[29] | Holstege H , Hoozemans JMM , van Woerden N , Wemmenhove E , Pieterse K , Schouten K , Meijers-Heijboer H , Scheltens P , Rozemuller A ((2015) ) Pathology of cognitively healthy centenarians. Alzheimers Dement 11: (Suppl 7), P257. |
[30] | Wang HX , MacDonald SW , Dekhtyar S , Fratiglioni L ((2017) ) Association of lifelong exposure to cognitive reserve-enhancing factors with dementia risk: A community-based cohort study. PLoS Med 14: , e1002251. |
[31] | Wu YT , Beiser AS , Breteler MMB , Fratiglioni L , Helmer C , Hendrie HC , Honda H , Ikram MA , Langa KM , Lobo A , Matthews FE , Ohara T , Pérès K , Qiu C , Seshadri S , Sjölund BM , Skoog I , Brayne C ((2017) ) The changing prevalence and incidence of dementia over time - current evidence. Nat Rev Neurol 13: , 327–339. |
[32] | Hall KS , Gao S , Baiyewu O , Lane KA , Gureje O , Shen J , Ogunniyi A , Murrell JR , Unverzagt FW , Dickens J , Smith-Gamble V , Hendrie HC ((2009) ) Prevalence rates for dementia and Alzheimer’s disease in African Americans: 1992 versus 2001. Alzheimers Dement 5: , 227–233. |
[33] | Kosteniuk JG , Morgan DG , O’Connell ME , Kirk A , Crossley M , Teare GF , Stewart NJ , Bello-Haas VD , McBain L , Mou H , Forbes DA , Innes A , Quail JM ((2016) ) Simultaneous temporal trends in dementia incidence and prevalence, 2005-2013: A population-based retrospective cohort study in Saskatchewan, Canada. Int Psychogeriatr 28: , 1643–1658. |
[34] | Langa KM , Larson EB , Crimmins EM , Faul JD , Levine DA , Kabeto MU , Weir DR ((2017) ) A comparison of the prevalence of dementia in the United States in 2000 and 2012. JAMA Intern Med 177: , 51–58. |
[35] | Lobo A , Saz P , Marcos G , Dia JL , De-la-Camara C , Ventura T , Montañes JA , Lobo-Escolar A , Aznar S ((2007) ) Prevalence of dementia in a southern European population in two different time periods: The ZARADEMP Project. Acta Psychiatr Scand 116: , 299–307. |
[36] | Qiu C , von Strauss E , Bäckman L , Winblad B , Fratiglioni L ((2013) ) Twenty-year changes in dementia occurrence suggest decreasing incidence in central Stockholm, Sweden. Neurology 80: , 1888–1894 |
[37] | Wiberg P , Waern M , Billstedt E , Ostling S , Skoog I ((2013) ) Secular trends in the prevalence of dementia and depression in Swedish septuagenarians 1976-2006. Psychol Med 43: , 2627–2634. |
[38] | Matthews FE , Arthur A , Barnes LE , Bond J , Jagger C , Robinson L , Brayne C ((2013) ) A two-decade comparison of prevalence of dementia in individuals aged 65 years and older from three geographical areas of England: Results of the Cognitive Function and Ageing Study I and II. Lancet 382: , 1405–1412. |
[39] | Wimo A , Sjölund BM , Sköldunger A , Qiu C , Klarin I , Nordberg G , von Strauss E ((2016) ) Cohort effects in the prevalence and survival of people with dementia in a rural area in northern Sweden. J Alzheimers Dis 50: , 387–396 |
[40] | Doblhammer G , Fink A , Fritze T ((2015) ) Short-term trends in dementia prevalence in Germany between the years 2007 and 2009. Alzheimers Dement 11: , 291–299. |
[41] | Pérès K , Brayne C , Matharan F , Grasset L , Helmer C , Letenneur L , Foubert-Samier A , Baldi I , Tison F , Amieva H , Dartigues JF ((2017) ) Trends in prevalence of dementia in French farmers from two epidemiological cohorts. J Am Geriatr Soc 65: , 415–420. |
[42] | Ahmadi-Abhari S , Guzman-Castillo M , Bandosz P , Shipley MJ , Muniz-Terrera G , Singh-Manoux A , Kivimäki M , Steptoe A , Capewell S , O’Flaherty M , Brunner EJ ((2017) ) Temporal trend in dementia incidence since 2002 and projections for prevalence in England and Wales to 2040: Modelling study. BMJ 358: , j2856. |
[43] | Skoog I , Börjesson-Hanson A , Kern S , Johansson L , Falk H , Sigström R , Östling S ((2017) ) Decreasing prevalence of dementia in 85-year olds examined 22 years apart: The influence of education and stroke. Sci Rep 7: , 6136. |
[44] | Li S , Yan F , Li G , Chen C , Zhang W , Liu J , Jia X , Shen Y ((2007) ) Is the dementia rate increasing in Beijing? Prevalence and incidence of dementia 10 years later in an urban elderly population. Acta Psychiatr Scand 115: , 73–79. |
[45] | Yu R , Chau PH , McGhee SM , Cheung WL , Chan KC , Cheung SH , Woo J ((2012) ) Trends in prevalence and mortality of dementia in elderly Hong Kong population: Projections, disease burden, and implications for long-term care. Int J Alzheimers Dis 2012: , 406852. |
[46] | Chan KY , Wang W , Wu JJ , Liu L , Theodoratou E , Car J , Middleton L , Russ TC , Deary IJ , Campbell H , Wang W , Rudan I ((2013) ) Epidemiology of Alzheimer’s disease and other forms of dementia in China, 1990-2010: A systematic review and analysis. Lancet 381: , 2016–2023. |
[47] | Kim YJ , Han JW , So YS , Seo JY , Kim KY , Kim KW ((2014) ) Prevalence and trends of dementia in Korea: A systematic review and meta-analysis. J Korean Med Sci 29: , 903–912. |
[48] | Ohara T , Hata J , Yoshida D , Mukai N , Nagata M , Iwaki T , Kitazono T , Kanba S , Kiyohara Y , Ninomiya T ((2017) ) Trends in dementia prevalence, incidence, and survival rate in a Japanese community. Neurology 88: , 1925–1932. |
[49] | Christensen K , Thinggaard M , Oksuzyan A , Steenstrup T , Andersen-Ranberg K , Jeune B , McGue M , Vaupel JW ((2013) ) Physical and cognitive functioning of people older than 90 years: A comparison of two Danish cohorts born 10 years apart. Lancet 382: , 1507–1513. |
[50] | Rocca WA , Petersen RC , Knopman DS , Hebert LE , Evans DA , Hall KS , Gao S , Unverzagt FW , Langa KM , Larson EB , White LR ((2011) ) Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States. Alzheimers Dement 7: , 80–93. |
[51] | Wu YT , Lee HY , Norton S , Prina AM , Fleming J , Matthews FE , Brayne C ((2014) ) Period, birth cohort and prevalence of dementia in mainland China, Hong Kong and Taiwan: A meta-analysis. Int J Geriatr Psychiatry 29: , 1212–1220. |
[52] | Zeng Y , Feng Q , Hesketh T , Christensen K , Vaupel JW ((2017) ) Survival, disabilities in activities of daily living, and physical and cognitive functioning among the oldest-old in China: A cohort study. Lancet 389: , 1619–1629. |
[53] | Dodge HH , Buracchio TJ , Fisher GG , Kiyohara Y , Meguro K , Tanizaki Y , Kaye JA ((2012) ) Trends in the prevalence of dementia in Japan. Int J Alzheimers Dis 2012: , 956354. |
[54] | Hebert LE , Bienias JL , Aggarwal NT , Wilson RS , Bennett DA , Shah RC , Evans DA ((2010) ) Change in risk of Alzheimer disease over time. Neurology 75: , 786–791. |
[55] | Gao S , Ogunniyi A , Hall KS , Baiyewu O , Unverzagt FW , Lane KA , Murrell JR , Gureje O , Hake AM , Hendrie HC ((2016) ) Dementia incidence declined in African-Americans but not in Yoruba. Alzheimers Dement 12: , 244–251. |
[56] | Satizabal CL , Beiser AS , Chouraki V , Chêne G , Dufouil C , Seshadri S ((2016) ) Incidence of dementia over three decades in the Framingham Heart Study. N Engl J Med 374: , 523–532. |
[57] | Cerasuolo JO , Cipriano LE , Sposato LA , Kapral MK , Fang J , Gill SS , Hackam DG , Hachinski V ((2017) ) Population-based stroke and dementia incidence trends: Age and sex variations. Alzheimers Dement 13: , 1081–1088. |
[58] | Derby CA , Katz MJ , Lipton RB , Hall CB ((2017) ) Trends in dementia incidence in a birth cohort analysis of the Einstein Aging Study. JAMA Neurol 74: , 1345–1351. |
[59] | Noble JM , Schupf N , Manly JJ , Andrews H , Tang MX , Mayeux R ((2017) ) Secular trends in the incidence of dementia in a multi-ethnic community. J Alzheimers Dis 60: , 1065–1075. |
[60] | Schrijvers EM , Verhaaren BF , Koudstaal PJ , Hofman A , Ikram MA , Breteler MM ((2012) ) Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology 78: , 1456–1463. |
[61] | Doblhammer G , Fink A , Zylla S , Willekens F ((2015) ) Compression or expansion of dementia in Germany? An observational study of short-term trends in incidence and death rates of dementia between 2006/07 and 2009/10 based on German health insurance data. Alzheimers Res Ther 7: , 66. |
[62] | Matthews FE , Stephan BC , Robinson L , Jagger C , Barnes LE , Arthur A , Brayne C ((2016) ) A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun 7: , 11398. |
[63] | Grasset L , Brayne C , Joly P , Jacqmin-Gadda H , Pérès K , Foubert-Samier A , Dartigues JF , Helmer C ((2016) ) Trends in dementia incidence: Evolution over a 10-year period in France. Alzheimers Dement 12: , 272–280. |
[64] | van Bussel EF , Richard E , Arts DL , Nooyens AC , Coloma PM , de Waal MW , van den Akker M , Biermans MC , Nielen MM , van Boven K , Smeets H , Matthews FE , Brayne C , Busschers WB , van Gool WA , Moll van Charante EP ((2017) ) Dementia incidence trend over 1992-2014 in the Netherlands: Analysis of primary care data. PLoS Med 14: , e1002235. |
[65] | Langa KM , Larson EB , Karlawish JH , Cutler DM , Kabeto MU , Kim SY , Rosen AB ((2008) ) Trends in the prevalence and mortality of cognitive impairment in the United States: Is there evidence of a compression of cognitive morbidity? Alzheimers Dement 4: , 134–144. |
[66] | Jagger C , Matthews FE , Wohland P , Fouweather T , Stephan BC , Robinson L , Arthur A , Brayne C ((2016) ) A comparison of health expectancies over two decades in England: Results of the Cognitive Function and Ageing Study I and II. Lancet 387: , 779–786. |
[67] | Crimmins EM , Saito Y , Kim JK ((2016) ) Change in cognitively healthy and cognitively impaired life expectancy in the United States: 2000-2010. SSM Popul Health 2: , 793–797. |
[68] | Yang G , Wang Y , Zeng Y , Gao GF , Liang X , Zhou M , Wan X , Yu S , Jiang Y , Naghavi M , Vos T , Wang H , Lopez AD , Murray CJ ((2013) ) Rapid health transition in China, 1990-2010: Findings from the Global Burden of Disease Study 2010. Lancet 381: , 1987–2015. |
[69] | Qiu C ((2012) ) Preventing Alzheimer’s disease by targeting vascular risk factors: Hope and gap. J Alzheimers Dis 32: , 721–731. |
[70] | Gorelick PB , Furie KL , Iadecola C , Smith EE , Waddy SP , Lloyd-Jones DM , Bae HJ , Bauman MA , Dichgans M , Duncan PW , Girgus M , Howard VJ , Lazar RM , Seshadri S , Testai FD , van Gaal S , Yaffe K , Wasiak H , Zerna C ((2017) ) Defining optimal brain health in adults: A presidential advisory from the American Heart Association/American Stroke Association. Stroke 48: , e284–e303. |
[71] | Qiu C , Fratiglioni L ((2015) ) A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol 12: , 267–277. |
[72] | Pase MP , Satizabal CL , Seshadri S ((2017) ) Role of improved vascular health in the declining incidence of dementia. Stroke 48: , 2013–2020. |
[73] | Qiu C ((2011) ) Epidemiological findings of vascular risk factors in Alzheimer’s disease: Implications for therapeutic and preventive intervention. Expert Rev Neurother 11: , 1593–1607. |
[74] | Ngandu T , Lehtisalo J , Solomon A , Levälahti E , Ahtiluoto S , Antikainen R , Bäckman L , Hänninen T , Jula A , Laatikainen T , Lindström J , Mangialasche F , Paajanen T , Pajala S , Peltonen M , Rauramaa R , Stigsdotter-Neely A , Strandberg T , Tuomilehto J , Soininen H , Kivipelto M ((2015) ) A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomized controlled trial. Lancet 385: , 2255–2263. |
[75] | Moll van Charante EP , Richard E , Eurelings LS , van Dalen JW , Ligthart SA , van Bussel EF , Hoevenaar-Blom MP , Vermeulen M , van Gool WA ((2016) ) Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): A cluster-randomised controlled trial. Lancet 388: , 797–805. |
[76] | Andrieu S , Guyonnet S , Coley N , Cantet C , Bonnefoy M , Bordes S , Bories L , Cufi MN , Dantoine T , Dartigues JF , Desclaux F , Gabelle A , Gasnier Y , Pesce A , Sudres K , Touchon J , Robert P , Rouaud O , Legrand P , Payoux P , Caubere JP , Weiner M , Carrié I , Ousset PJ , Vellas B ((2017) ) Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): A randomised, placebo-controlled trial. Lancet Neurol 16: , 377–389. |
[77] | Yates LA , Ziser S , Spector A , Orrell M ((2016) ) Cognitive leisure activities and future risk of cognitive impairment and dementia: Systematic review and meta-analysis. Int Psychogeriatr 28: , 1791–1806. |
